4//SEC Filing
Wambeke David J. 4
Accession 0001235802-23-000040
CIK 0001401040other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 5:40 PM ET
Size
7.1 KB
Accession
0001235802-23-000040
Insider Transaction Report
Form 4
Wambeke David J.
Chief Business Officer
Transactions
- Purchase
Voting Common Shares, no par value per share
2023-04-10$1.60/sh+468,750$750,000→ 468,750 total - Award
Stock Option (right to buy)
2023-04-10+140,000→ 140,000 totalExercise: $1.57Exp: 2033-04-09→ Common Shares (140,000 underlying)
Footnotes (1)
- [F1]This option vests with respect to 35,000 common shares on April 10, 2024 and with respect to the remaining 75% of the common shares in 12 as nearly equal as possible quarterly installments commencing three months after the one-year anniversary of the grant date.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001971798
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 5:40 PM ET
- Size
- 7.1 KB